Servicebio Snags ￥10M in Series A Financing

According to PEdaily.cn, recently, Wuhan Service Biotechnology Co., Ltd. ("Servicebio") has raised tens of millions of yuan in Series A with exclusive participation from Silicon Paradise Asset Management Group. Proceeds from the latest round will be used to accelerate the Servicebio's product research and development and market expansion.

Founded in 2007 and located in the biomedical park of Biolake in Wuhan, Servicebio is a high-tech company providing laboratory services and research reagents. Its laboratory services cover the pathological experiments, animal experiments, experiments on cells, proteins, antibodies, special staining, and other fields. It provides consumables and reagents including commonly-used secondary antibodies, staining reagents, a full range of WEB testing reagents, etc.

At present, Servicebio has built independent laboratories in Beijing, Shanghai, Guangzhou, Nanjing and other cities, and more than 40 service centers in large and medium-sized cities in China. It also has laboratories in the USA's Boston and Germany's Duisburg.

Servicebio has its own product development platform and comprehensive service platform. While providing customers with high-quality scientific research services, the company also sells to customers with testing reagents, consumables, and other products. At present, Servicebio has a team of more than 1,000 people, serving more than 30,000 customers.

TTGG was founded on Nov. 11, 2000. It has become one of the largest private equity companies in China, No. 1 in Zhejiang Province, China. Currently, the company has registered capital of RMB1.2 billion. With this competitive edge, TTGG is able to provide quality financial services in the fields such as M&A, VC/PE, PIPE, mezzanine fund, FOF and etc. 

TTGG's investment is now focusing on the industries of TMT, advanced manufacturing, energy saving and environment, modern agriculture, health, and financial services.